Cream with pimecrolimus, a lipophilic anti-inflammatory ascomycin macrolactam derivative and a cell selective inhibitor of the production and release of pro-inflammatory cytokines. Its skin-selective pharmacological profile is different to that of corticosteroids.
Short term or intermittent treatment of mild or moderate atopic dermatitis where use of topical steroids is inadvisable or not possible.
30g, £19.69; 60g, £37.41; 100g, £59.07
More on: Topical eczema treatments